# A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants

> **NCT06058390** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 160 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Bepirovirsen

## Key facts

- **NCT ID:** NCT06058390
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-04
- **Primary completion:** 2024-05-03
- **Final completion:** 2024-05-03
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06058390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06058390, "A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06058390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*